Severe Polyhydramnios with Consistent Fetal Full Bladder: A Novel Sign of Antenatal Bartter's Disease

被引:3
|
作者
Thakur, Seema [1 ]
Kumar, Manisha [2 ]
Malhotra, Supriya [3 ]
Paliwal, Preeti [4 ]
Thareja, Vandana [5 ]
Sahi, Gaurika [6 ]
机构
[1] Fortis Hosp, Dept Genet & Fetal Diag, AA Block, New Delhi 110088, India
[2] Lady Hardinge Med Coll & Hosp, Dept Obstet & Gynaecol, Dept Med Genet, New Delhi, India
[3] Fortis La Femme, Dept Obstet & Gynaecol, New Delhi, India
[4] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi, India
[5] Vandana Diagnost, Dept Radiol, Delhi, India
[6] Fortis La Femme, Dept Radiol, New Delhi, India
关键词
polyhydramnios; overdistended bladder; Bartter's disease; SLC21A1; KCNJ1; PRENATAL-DIAGNOSIS; AMNIOTIC-FLUID;
D O I
10.1055/s-0040-1713157
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Bartter's disease, an inherited renal tubular disorder is due to a defect in ion transport across the ascending limb of the loop of Henle leading to failure of the ability of kidneys to concentrate urine and hence polyuria. We present three fetuses of mothers with severe polyhydramnios with normal maternal blood sugar profile, routine Toxoplasma, Rubella, Cytomegalovirus, Herpes (TORCH) serology. The ultrasound showed no structural anomaly in the fetus, but consistent overdistended bladder with severe polyhydramnios was observed without any evidence of obstructive uropathy. The biochemical test on amniotic fluid was suggestive of Bartter's disease in case 1 and borderline in case 2, and next-generation sequencing confirmed a mutation of KCNJ1 associated with Bartter's disease Type II in case 1 and a mutation in SLC21A1 in case 2. Amniotic fluid biochemistry was inconclusive in case 3. A consistent full bladder with severe polyhydramnios with onset around 24 to 25 weeks was a novel finding which was observed due to fetal polyuria and can be used as a clue to investigate cases with severe polyhydramnios with no structural anomaly. Antenatal diagnosis will help in the proper management of child and genetic counseling for the next pregnancy.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 50 条
  • [31] Exome Sequencing Identify Novel Variants in African-Americans With Severe Perianal and Colonic Crohn's Disease
    Kugathasan, Subra
    Okou, David T.
    Mondal, Kajari
    Benjamin, Adam L.
    Kumar, Archana
    Hussain, Sunny Z.
    Katz, Jeffry
    Cross, Raymond
    Moulton, Dedrick E.
    Cutler, David J.
    Zwick, Michael E.
    GASTROENTEROLOGY, 2013, 144 (05) : S465 - S465
  • [32] Evaluation of complications of treatment of severe Blount's disease by circular external fixation using a novel classification scheme
    Cherkashin, Alexander M.
    Samchukov, Mikhail L.
    Birch, John G.
    Da Cunha, Ana L. Munhoz
    JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B, 2015, 24 (02): : 123 - 130
  • [33] Novel pathogenic variants in GBE1 causing fetal akinesia deformation sequence and severe neuromuscular form of glycogen storage disease type IV
    Radhakrishnan, Periyasamy
    Moirangthem, Amita
    Nayak, Shalini S.
    Shukla, Anju
    Mathew, Mary
    Girisha, Katta M.
    CLINICAL DYSMORPHOLOGY, 2019, 28 (01) : 17 - 21
  • [34] Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study
    Schmitt, F. A.
    Saxton, J.
    Ferris, S. H.
    Mackell, J.
    Sun, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (10) : 1050 - 1056
  • [35] Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
    Annika Öhrfelt
    Julien Dumurgier
    Henrik Zetterberg
    Agathe Vrillon
    Nicholas J. Ashton
    Hlin Kvartsberg
    Elodie Bouaziz-Amar
    Jacques Hugon
    Claire Paquet
    Kaj Blennow
    Alzheimer's Research & Therapy, 12
  • [36] Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
    ohrfelt, Annika
    Dumurgier, Julien
    Zetterberg, Henrik
    Vrillon, Agathe
    Ashton, Nicholas J.
    Kvartsberg, Hlin
    Bouaziz-Amar, Elodie
    Hugon, Jacques
    Paquet, Claire
    Blennow, Kaj
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [37] Efficacy and safety of sargramostimt in moderate to severe Crohn's disease: Results of NOVEL 4, a phase III multicenter study
    Feagan, Brian G.
    Anderson, Frank
    Radford-smith, Gnaharn L.
    Solovyov, Oleg
    Zurdel-dillinger, Sabine
    GASTROENTEROLOGY, 2007, 132 (04) : A103 - A103
  • [38] Mass spectrometry detects lower frequency of routine markers and consistent overexpression of novel disease drivers in Barrett's-related esophageal cancer
    Hartley, Christopher
    Bansal, Ajay
    Hagen, Catherine
    Driscoll, Olivia
    Oh, Seyun
    Abdo, Joe
    Mittal, Sumeet K.
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Natalizumab provides consistent induction efficacy for patients with moderate to severe Crohn's disease and elevated C-reactive protein: A comparison of ENACT-1 and ENCORE
    Wolf, D.
    Bornstein, J.
    Hernandez, C.
    Colombel, J. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S445 - S445
  • [40] Novel Highly Effective Medical Treatment of Severe Treatment: Refractory Crohn's Disease Using Sympathomimetic Amines: Case Report
    Check, Jerome H.
    Katsoff, Brittney
    Cohen, Rachael
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (12) : 1999 - 2000